Jozwiak, M.Oude Rengerink, K.Benthem, M.van Beek, E.Dijksterhuis, M.de Graaf, I.van Huizen, M.Oudijk, M.Papatsonis, D.Perquin, D.Porath, M.van der Post, J.Rijnders, R.Scheepers, L.Spaanderman, M.van Pampus, M.de Leeuw, J.Mol, B.Bloemenkamp, K.2015-01-072015-01-072011The Lancet, 2011; 378(9809):2095-21030140-67361474-547Xhttp://hdl.handle.net/2440/88520Abstract not availableen© 2011 Elsevier Ltd. All rights reserved.PROBAAT Study GroupHumansOxytocicsDinoprostoneCatheterizationDelivery, ObstetricCesarean SectionLabor, InducedPregnancyCervical RipeningAdultFemaleVaginal Creams, Foams, and JelliesFoley catheter versus vaginal prostaglandin E2 gel for induction of labour at term (PROBAAT trial): An open-label, randomised controlled trialJournal article002013678010.1016/S0140-6736(11)61484-00002982936000312-s2.0-8395516420515375Mol, B. [0000-0001-6887-0262] [0000-0001-8337-550X]